Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study

Fig. 1

Flow chart showing the selection of patients from the original data extraction, to the base cohort, and to the final study cohort at baseline. Combined users had a prescription of a combination of at least two of the study drugs. SGLT2-I sodium-glucose co-transporter-2 inhibitor, GLP1-RA glucagon-like peptide-1 receptor agonist, SU sulfonylurea, DPP4-I dipeptidyl peptidase-4 inhibitor

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840